UniProt ID | NFAC4_HUMAN | |
---|---|---|
UniProt AC | Q14934 | |
Protein Name | Nuclear factor of activated T-cells, cytoplasmic 4 | |
Gene Name | NFATC4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 902 | |
Subcellular Localization | Cytoplasm . Nucleus . Cytoplasmic for the phosphorylated form and nuclear after activation that is controlled by calcineurin-mediated dephosphorylation. Rapid nuclear exit of NFATC is thought to be one mechanism by which cells distinguish between sus | |
Protein Description | Plays a role in the inducible expression of cytokine genes in T-cells, especially in the induction of the IL-2 and IL-4. Transcriptionally repressed by estrogen receptors; this inhibition is further enhanced by estrogen. Increases the transcriptional activity of PPARG and has a direct role in adipocyte differentiation. May play an important role in myotube differentiation. May play a critical role in cardiac development and hypertrophy. May play a role in deafferentation-induced apoptosis of sensory neurons.. | |
Protein Sequence | MGAASCEDEELEFKLVFGEEKEAPPLGAGGLGEELDSEDAPPCCRLALGEPPPYGAAPIGIPRPPPPRPGMHSPPPRPAPSPGTWESQPARSVRLGGPGGGAGGAGGGRVLECPSIRITSISPTPEPPAALEDNPDAWGDGSPRDYPPPEGFGGYREAGGQGGGAFFSPSPGSSSLSSWSFFSDASDEAALYAACDEVESELNEAASRFGLGSPLPSPRASPRPWTPEDPWSLYGPSPGGRGPEDSWLLLSAPGPTPASPRPASPCGKRRYSSSGTPSSASPALSRRGSLGEEGSEPPPPPPLPLARDPGSPGPFDYVGAPPAESIPQKTRRTSSEQAVALPRSEEPASCNGKLPLGAEESVAPPGGSRKEVAGMDYLAVPSPLAWSKARIGGHSPIFRTSALPPLDWPLPSQYEQLELRIEVQPRAHHRAHYETEGSRGAVKAAPGGHPVVKLLGYSEKPLTLQMFIGTADERNLRPHAFYQVHRITGKMVATASYEAVVSGTKVLEMTLLPENNMAANIDCAGILKLRNSDIELRKGETDIGRKNTRVRLVFRVHVPQGGGKVVSVQAASVPIECSQRSAQELPQVEAYSPSACSVRGGEELVLTGSNFLPDSKVVFIERGPDGKLQWEEEATVNRLQSNEVTLTLTVPEYSNKRVSRPVQVYFYVSNGRRKRSPTQSFRFLPVICKEEPLPDSSLRGFPSASATPFGTDMDFSPPRPPYPSYPHEDPACETPYLSEGFGYGMPPLYPQTGPPPSYRPGLRMFPETRGTTGCAQPPAVSFLPRPFPSDPYGGRGSSFSLGLPFSPPAPFRPPPLPASPPLEGPFPSQSDVHPLPAEGYNKVGPGYGPGEGAPEQEKSRGGYSSGFRDSVPIQGITLEEVSEIIGRDLSGFPAPPGEEPPA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 (in isoform 11) | Phosphorylation | - | 8.56 | 24043423 | |
3 (in isoform 2) | Phosphorylation | - | 8.56 | 24043423 | |
3 (in isoform 3) | Phosphorylation | - | 8.56 | 24043423 | |
4 (in isoform 11) | Phosphorylation | - | 14.69 | 24043423 | |
4 (in isoform 2) | Phosphorylation | - | 14.69 | 24043423 | |
4 (in isoform 3) | Phosphorylation | - | 14.69 | 24043423 | |
5 | Phosphorylation | ---MGAASCEDEELE ---CCCCCCCCCEEE | 19.94 | 29514088 | |
7 (in isoform 11) | Phosphorylation | - | 67.00 | 24043423 | |
7 (in isoform 2) | Phosphorylation | - | 67.00 | 24043423 | |
7 (in isoform 3) | Phosphorylation | - | 67.00 | 24043423 | |
12 (in isoform 11) | Phosphorylation | - | 43.97 | 24043423 | |
12 (in isoform 2) | Phosphorylation | - | 43.97 | 24043423 | |
12 (in isoform 3) | Phosphorylation | - | 43.97 | 24043423 | |
15 (in isoform 11) | Phosphorylation | - | 4.72 | 24043423 | |
15 (in isoform 2) | Phosphorylation | - | 4.72 | 24043423 | |
15 (in isoform 3) | Phosphorylation | - | 4.72 | 24043423 | |
17 (in isoform 11) | Phosphorylation | - | 17.25 | 24043423 | |
17 (in isoform 2) | Phosphorylation | - | 17.25 | 24043423 | |
17 (in isoform 3) | Phosphorylation | - | 17.25 | 24043423 | |
35 (in isoform 11) | Phosphorylation | - | 8.37 | 25332170 | |
35 (in isoform 2) | Phosphorylation | - | 8.37 | 25332170 | |
35 (in isoform 3) | Phosphorylation | - | 8.37 | 25332170 | |
43 (in isoform 11) | Phosphorylation | - | 1.73 | 25332170 | |
43 (in isoform 2) | Phosphorylation | - | 1.73 | 25332170 | |
43 (in isoform 3) | Phosphorylation | - | 1.73 | 25332170 | |
44 (in isoform 11) | Phosphorylation | - | 5.01 | 25332170 | |
44 (in isoform 2) | Phosphorylation | - | 5.01 | 25332170 | |
44 (in isoform 3) | Phosphorylation | - | 5.01 | 25332170 | |
52 | Phosphorylation | RLALGEPPPYGAAPI CHHCCCCCCCCCCCC | 30.37 | 32142685 | |
73 | Phosphorylation | PPRPGMHSPPPRPAP CCCCCCCCCCCCCCC | 30.15 | 26329039 | |
110 | Phosphorylation | GGAGGGRVLECPSIR CCCCCCCEEECCCEE | 6.29 | 32142685 | |
115 | Phosphorylation | GRVLECPSIRITSIS CCEEECCCEEEEEEC | 35.84 | 28555341 | |
119 | Phosphorylation | ECPSIRITSISPTPE ECCCEEEEEECCCCC | 15.34 | 27251275 | |
120 | Phosphorylation | CPSIRITSISPTPEP CCCEEEEEECCCCCC | 20.78 | 27251275 | |
122 | Phosphorylation | SIRITSISPTPEPPA CEEEEEECCCCCCCC | 23.61 | 19690332 | |
124 | Phosphorylation | RITSISPTPEPPAAL EEEEECCCCCCCCHH | 33.23 | 30576142 | |
136 (in isoform 3) | Phosphorylation | - | 62.30 | 27251275 | |
142 | Phosphorylation | PDAWGDGSPRDYPPP CCCCCCCCCCCCCCC | 22.85 | 28842319 | |
143 | Phosphorylation | DAWGDGSPRDYPPPE CCCCCCCCCCCCCCC | 38.40 | 32142685 | |
147 | Phosphorylation | DGSPRDYPPPEGFGG CCCCCCCCCCCCCCC | 42.11 | 32142685 | |
156 | Phosphorylation | PEGFGGYREAGGQGG CCCCCCCCCCCCCCC | 30.48 | 32142685 | |
168 | Phosphorylation | QGGGAFFSPSPGSSS CCCCCCCCCCCCCCC | 20.29 | 11997522 | |
170 | Phosphorylation | GGAFFSPSPGSSSLS CCCCCCCCCCCCCCC | 40.47 | 11997522 | |
173 | Phosphorylation | FFSPSPGSSSLSSWS CCCCCCCCCCCCCCC | 21.82 | - | |
185 | Phosphorylation | SWSFFSDASDEAALY CCCCCCCCCCHHHHH | 20.06 | 32142685 | |
185 (in isoform 3) | Phosphorylation | - | 20.06 | 24719451 | |
194 | Phosphorylation | DEAALYAACDEVESE CHHHHHHHHHHHHHH | 6.42 | 32142685 | |
201 | Phosphorylation | ACDEVESELNEAASR HHHHHHHHHHHHHHH | 41.95 | 32142685 | |
205 | Phosphorylation | VESELNEAASRFGLG HHHHHHHHHHHHCCC | 15.06 | 32142685 | |
213 | Phosphorylation | ASRFGLGSPLPSPRA HHHHCCCCCCCCCCC | 28.45 | 25463755 | |
214 | Phosphorylation | SRFGLGSPLPSPRAS HHHCCCCCCCCCCCC | 46.63 | 32142685 | |
217 | Phosphorylation | GLGSPLPSPRASPRP CCCCCCCCCCCCCCC | 34.40 | 25463755 | |
219 | Phosphorylation | GSPLPSPRASPRPWT CCCCCCCCCCCCCCC | 52.62 | 32142685 | |
221 | Phosphorylation | PLPSPRASPRPWTPE CCCCCCCCCCCCCCC | 23.79 | 28450419 | |
226 | Phosphorylation | RASPRPWTPEDPWSL CCCCCCCCCCCCCHH | 21.34 | 28450419 | |
232 | Phosphorylation | WTPEDPWSLYGPSPG CCCCCCCHHCCCCCC | 19.66 | 27732954 | |
234 | Phosphorylation | PEDPWSLYGPSPGGR CCCCCHHCCCCCCCC | 22.83 | 19651622 | |
237 | Phosphorylation | PWSLYGPSPGGRGPE CCHHCCCCCCCCCCC | 31.64 | 21712546 | |
241 | Phosphorylation | YGPSPGGRGPEDSWL CCCCCCCCCCCCCEE | 64.51 | 32142685 | |
246 | Phosphorylation | GGRGPEDSWLLLSAP CCCCCCCCEEEEECC | 20.26 | 26074081 | |
251 | Phosphorylation | EDSWLLLSAPGPTPA CCCEEEEECCCCCCC | 32.18 | 30576142 | |
252 | Phosphorylation | DSWLLLSAPGPTPAS CCEEEEECCCCCCCC | 17.03 | 32142685 | |
256 | Phosphorylation | LLSAPGPTPASPRPA EEECCCCCCCCCCCC | 37.08 | 28450419 | |
259 | Phosphorylation | APGPTPASPRPASPC CCCCCCCCCCCCCCC | 23.73 | 21712546 | |
264 | Phosphorylation | PASPRPASPCGKRRY CCCCCCCCCCCCCCC | 24.33 | 22617229 | |
271 | Phosphorylation | SPCGKRRYSSSGTPS CCCCCCCCCCCCCCC | 19.55 | 30087585 | |
272 | Phosphorylation | PCGKRRYSSSGTPSS CCCCCCCCCCCCCCC | 19.06 | 21712546 | |
273 | Phosphorylation | CGKRRYSSSGTPSSA CCCCCCCCCCCCCCC | 24.69 | 28450419 | |
274 | Phosphorylation | GKRRYSSSGTPSSAS CCCCCCCCCCCCCCC | 40.52 | 26699800 | |
276 | Phosphorylation | RRYSSSGTPSSASPA CCCCCCCCCCCCCHH | 23.19 | 27732954 | |
276 (in isoform 3) | Phosphorylation | - | 23.19 | 24719451 | |
277 | Phosphorylation | RYSSSGTPSSASPAL CCCCCCCCCCCCHHH | 29.79 | 32142685 | |
278 | Phosphorylation | YSSSGTPSSASPALS CCCCCCCCCCCHHHH | 38.07 | 28450419 | |
279 | Phosphorylation | SSSGTPSSASPALSR CCCCCCCCCCHHHHC | 33.69 | 28450419 | |
280 | Phosphorylation | SSGTPSSASPALSRR CCCCCCCCCHHHHCC | 24.70 | 32142685 | |
280 (in isoform 3) | Phosphorylation | - | 24.70 | 24719451 | |
281 | Phosphorylation | SGTPSSASPALSRRG CCCCCCCCHHHHCCC | 16.80 | 27732954 | |
284 (in isoform 3) | Phosphorylation | - | 4.67 | 27251275 | |
285 | Phosphorylation | SSASPALSRRGSLGE CCCCHHHHCCCCCCC | 23.26 | 27732954 | |
289 | Phosphorylation | PALSRRGSLGEEGSE HHHHCCCCCCCCCCC | 31.24 | 30266825 | |
289 (in isoform 3) | Phosphorylation | - | 31.24 | 24719451 | |
295 | Phosphorylation | GSLGEEGSEPPPPPP CCCCCCCCCCCCCCC | 50.65 | 30278072 | |
299 | Phosphorylation | EEGSEPPPPPPLPLA CCCCCCCCCCCCCCC | 65.82 | 32142685 | |
311 | Phosphorylation | PLARDPGSPGPFDYV CCCCCCCCCCCCCCC | 31.88 | 21712546 | |
317 | Phosphorylation | GSPGPFDYVGAPPAE CCCCCCCCCCCCCHH | 10.93 | 27251789 | |
322 (in isoform 3) | Phosphorylation | - | 48.39 | 24719451 | |
325 | Phosphorylation | VGAPPAESIPQKTRR CCCCCHHHCCCCCCC | 41.49 | 22199227 | |
327 | Phosphorylation | APPAESIPQKTRRTS CCCHHHCCCCCCCCC | 38.60 | 32142685 | |
327 (in isoform 3) | Phosphorylation | - | 38.60 | 24719451 | |
330 | Phosphorylation | AESIPQKTRRTSSEQ HHHCCCCCCCCCHHH | 21.82 | 23882029 | |
333 | Phosphorylation | IPQKTRRTSSEQAVA CCCCCCCCCHHHCCC | 33.06 | 23403867 | |
334 | Phosphorylation | PQKTRRTSSEQAVAL CCCCCCCCHHHCCCC | 30.02 | 23911959 | |
335 | Phosphorylation | QKTRRTSSEQAVALP CCCCCCCHHHCCCCC | 32.87 | 21712546 | |
335 (in isoform 3) | Phosphorylation | - | 32.87 | 24719451 | |
337 (in isoform 3) | Phosphorylation | - | 42.98 | 27251275 | |
339 (in isoform 3) | Phosphorylation | - | 5.85 | 27251275 | |
344 | Phosphorylation | QAVALPRSEEPASCN HCCCCCCCCCCCCCC | 44.35 | 28112733 | |
344 (in isoform 3) | Phosphorylation | - | 44.35 | 24719451 | |
349 | Phosphorylation | PRSEEPASCNGKLPL CCCCCCCCCCCCCCC | 20.87 | 28555341 | |
352 | Phosphorylation | EEPASCNGKLPLGAE CCCCCCCCCCCCCCC | 36.89 | 32142685 | |
352 (in isoform 3) | Phosphorylation | - | 36.89 | 24719451 | |
368 | Phosphorylation | SVAPPGGSRKEVAGM CCCCCCCCHHHCCCC | 46.20 | 28555341 | |
374 | Phosphorylation | GSRKEVAGMDYLAVP CCHHHCCCCEEEECC | 18.05 | 32142685 | |
374 (in isoform 3) | Phosphorylation | - | 18.05 | 24719451 | |
382 | Phosphorylation | MDYLAVPSPLAWSKA CEEEECCCCCCHHCC | 26.41 | 22199227 | |
387 | Phosphorylation | VPSPLAWSKARIGGH CCCCCCHHCCCCCCC | 15.72 | 30576142 | |
395 | Phosphorylation | KARIGGHSPIFRTSA CCCCCCCCCCCCCCC | 23.98 | 28555341 | |
397 (in isoform 3) | Phosphorylation | - | 4.01 | 24719451 | |
438 | Phosphorylation | AHYETEGSRGAVKAA HEECCCCCCCCHHCC | 22.70 | 23403867 | |
445 (in isoform 3) | Phosphorylation | - | 9.50 | 24719451 | |
468 | Ubiquitination | PLTLQMFIGTADERN CEEEEEEEECCCCCC | 3.93 | 29967540 | |
510 | Phosphorylation | GTKVLEMTLLPENNM CCEEEEEEECCCCCC | 18.77 | 22210691 | |
526 | Ubiquitination | ANIDCAGILKLRNSD CCCCCEEEHHHHCCC | 1.31 | 29967540 | |
532 | Phosphorylation | GILKLRNSDIELRKG EEHHHHCCCCEECCC | 33.27 | 28450419 | |
538 | Ubiquitination | NSDIELRKGETDIGR CCCCEECCCCCCCCC | 73.96 | 29967540 | |
592 | Phosphorylation | LPQVEAYSPSACSVR CCCCEEECCCCEEEC | 21.30 | 28555341 | |
595 (in isoform 3) | Phosphorylation | - | 7.93 | 24719451 | |
601 | Ubiquitination | SACSVRGGEELVLTG CCEEECCCCEEEEEC | 18.03 | 29967540 | |
653 | Phosphorylation | LTLTVPEYSNKRVSR EEEECCCCCCCCCCC | 16.09 | - | |
654 | Phosphorylation | TLTVPEYSNKRVSRP EEECCCCCCCCCCCC | 33.92 | - | |
676 | Phosphorylation | SNGRRKRSPTQSFRF ECCCCCCCCCCCEEE | 35.02 | 15657420 | |
689 | Sumoylation | RFLPVICKEEPLPDS EEEEEEECCCCCCCC | 54.72 | 28112733 | |
716 | Phosphorylation | FGTDMDFSPPRPPYP CCCCCCCCCCCCCCC | 29.72 | 24719451 | |
772 | Phosphorylation | FPETRGTTGCAQPPA CCCCCCCCCCCCCCC | 32.84 | - | |
788 | Ubiquitination | SFLPRPFPSDPYGGR EECCCCCCCCCCCCC | 40.27 | 29967540 | |
819 | Phosphorylation | RPPPLPASPPLEGPF CCCCCCCCCCCCCCC | 25.72 | 26074081 | |
846 | Ubiquitination | GYNKVGPGYGPGEGA CCCCCCCCCCCCCCC | 33.82 | 29967540 | |
858 | Ubiquitination | EGAPEQEKSRGGYSS CCCCHHHHCCCCCCC | 45.18 | 29967540 | |
921 | Ubiquitination | -------------------------- -------------------------- | 29967540 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
168 | S | Phosphorylation | Kinase | MK14 | Q16539 | PhosphoELM |
168 | S | Phosphorylation | Kinase | MAPK7 | Q13164 | Uniprot |
170 | S | Phosphorylation | Kinase | MK14 | Q16539 | PhosphoELM |
170 | S | Phosphorylation | Kinase | MAPK7 | Q13164 | Uniprot |
213 | S | Phosphorylation | Kinase | MAPK9 | Q9WTU6 | GPS |
213 | S | Phosphorylation | Kinase | JNK1 | P45983 | PSP |
213 | S | Phosphorylation | Kinase | MAPK8 | Q91Y86 | GPS |
213 | S | Phosphorylation | Kinase | JNK2 | P45984 | PSP |
217 | S | Phosphorylation | Kinase | MAPK9 | Q9WTU6 | GPS |
217 | S | Phosphorylation | Kinase | JNK1 | P45983 | PSP |
217 | S | Phosphorylation | Kinase | MAPK8 | Q91Y86 | GPS |
217 | S | Phosphorylation | Kinase | JNK2 | P45984 | PSP |
259 | S | Phosphorylation | Kinase | CDK3 | Q00526 | PSP |
281 | S | Phosphorylation | Kinase | RPS6KA3 | P51812 | GPS |
285 | S | Phosphorylation | Kinase | RPS6KA3 | P51812 | GPS |
289 | S | Phosphorylation | Kinase | RSK2 | P51812 | PSP |
344 | S | Phosphorylation | Kinase | RSK2 | P51812 | PSP |
676 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
676 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
676 | S | Phosphorylation | Kinase | RPS6KA3 | P51812 | GPS |
676 | S | Phosphorylation | Kinase | RSK-SUBFAMILY | - | GPS |
676 | S | Phosphorylation | Kinase | RSK_GROUP | - | PhosphoELM |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
48 | K | ubiquitylation |
| 19026640 |
168 | S | Phosphorylation |
| 11997522 |
168 | S | Phosphorylation |
| 11997522 |
170 | S | Phosphorylation |
| 11997522 |
170 | S | Phosphorylation |
| 11997522 |
213 | S | Phosphorylation |
| 17875713 |
217 | S | Phosphorylation |
| 17875713 |
289 | S | Phosphorylation |
| 17213202 |
344 | S | Phosphorylation |
| 17213202 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NFAC4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
LPIN1_HUMAN | LPIN1 | physical | 20385772 | |
CEBPA_HUMAN | CEBPA | physical | 20385772 | |
MK08_HUMAN | MAPK8 | physical | 17875713 | |
MK09_HUMAN | MAPK9 | physical | 17875713 | |
NR1I2_HUMAN | NR1I2 | physical | 21988832 | |
MK14_HUMAN | MAPK14 | physical | 25241761 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Integration of protein kinases mTOR and extracellular signal-regulated kinase 5 in regulating nucleocytoplasmic localization ofNFATc4."; Yang T.T.C., Yu R.Y.L., Agadir A., Gao G.-J., Campos-Gonzalez R.,Tournier C., Chow C.-W.; Mol. Cell. Biol. 28:3489-3501(2008). Cited for: SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT SER-168 AND SER-170. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-272 AND SER-334, ANDMASS SPECTROMETRY. | |
"RSK2 mediates muscle cell differentiation through regulation ofNFAT3."; Cho Y.-Y., Yao K., Bode A.M., Bergen H.R. III, Madden B.J., Oh S.-M.,Ermakova S., Kang B.S., Choi H.S., Shim J.-H., Dong Z.; J. Biol. Chem. 282:8380-8392(2007). Cited for: FUNCTION, INTERACTION WITH RPS6KA3, AND PHOSPHORYLATION AT SER-289 ANDSER-344. | |
"Nuclear factor of activated T3 is a negative regulator of Ras-JNK1/2-AP-1 induced cell transformation."; Yao K., Cho Y.-Y., Bergen H.R. III, Madden B.J., Choi B.Y., Ma W.-Y.,Bode A.M., Dong Z.; Cancer Res. 67:8725-8735(2007). Cited for: INTERACTION WITH MAPK8 AND MAPK9, PHOSPHORYLATION AT SER-213 ANDSER-217, AND MUTAGENESIS OF SER-213 AND SER-217. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-289, AND MASSSPECTROMETRY. | |
"Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases."; Yang T.T.C., Xiong Q., Enslen H., Davis R.J., Chow C.-W.; Mol. Cell. Biol. 22:3892-3904(2002). Cited for: FUNCTION, PHOSPHORYLATION AT SER-168 AND SER-170, AND MUTAGENESIS OFSER-168 AND SER-170. |